Purchase Order 75N93019P01001
Award Date
8/15/19
Potential Completion Date
12/13/19
Potential Value
$12K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Revvity Discovery LIMITED
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $14,810.64 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Horizon Discovery Biosciences LIMITED, a foreign-owned, for-profit manufacturer of genetic research materials. The award is for the supply of Horizon Discovery's SMARTVECTOR human whole genome lentiviral shRNA pooled library and associated USB plate map files. This specialized genetic...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $202,000.00 firm fixed price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for the "SIRNAS WITH ACCELL MODIFICATION PROJECT". The contract, which does not have a small business set-aside, is for the provision of various gene silencing and regulation products, including small interfering...
Horizon Discovery Biosciences LIMITED has been awarded a firm fixed price purchase order totaling one hundred twenty-one thousand two hundred ninety-four dollars and sixty-four cents ($121,294.64) by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to supply a Dharmacon Human On-TargetPlus Druggable Genome siRNA Library for the Functional Genomic Lab. The purchase order does not include any set-aside designations...
The Department of Health and Human Services' National Institutes of Health's National Center for Advancing Translational Sciences awarded a $13,474 purchase order to Horizon Discovery Biosciences Limited of Great Britain. Under the firm fixed price contract, Horizon Discovery will provide ON-TARGETPLUS MOUSE AAK1 small interfering RNA SMARTPOOL consisting of 50 nanomoles of the described product. Place of performance will be Great Britain, with work occurring between September 5 and November...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to Horizon Discovery Limited, a UK-based biotechnology company, for whole-genome CRISPR knockout gene interaction screening services. The contract, valued at $92,500, was awarded in support of NICHD research to translate genomic and genetic research into a greater understanding of human genetic disease and the...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NIH NCATS) awarded a $122,612.40 firm fixed-price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for 14 Mouse ON-TARGET plus small interfering RNA (siRNA) libraries. This non-competitive, brand-name acquisition was conducted under simplified acquisition procedures without any small business set-aside. The purchase...
This federal contract award to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, is for the delivery of small interfering RNA (siRNA) genome libraries. These specialized genetic research materials will be used by the Defense Health Agency to evaluate experimental systems. The $71,463.99 firm fixed-price purchase order does not have a set-aside designation, reflecting Horizon Discovery Biosciences' status as a large business. The parent company, Revvity Inc., is a...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,616.40 purchase order contract to Stemcell Technologies Inc. for cell lines. As the prime contractor, Stemcell Technologies will deliver cell lines to NIH/NIAID under the firm fixed price contract. Performance will take place in Kent, Washington over a one-year period from August 2023 through August 2024. No subcontractors or set aside designations were...
This federal contract award, identified as HHSN272201400873P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $7,335.00 firm-fixed-price purchase order was awarded to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products, to provide 15 units of AMBIS 1695546 PLASMID PREP, 3MG, CAT # 3000, at a...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a $25,085.25 firm-fixed-price purchase order contract to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned for-profit manufacturer of specialized genomic and proteomic research tools. The contract is for the delivery of custom DNA kits, specifically MYBAITS Custom 200-250K 48 RXNS for Trypanosomes, to support NIAID's biomedical research programs. This contract is...